Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

FDC116115: A prospective study of sexual function in sexually active men treated for BPH

Trial Profile

FDC116115: A prospective study of sexual function in sexually active men treated for BPH

Status: Completed
Phase of Trial: Phase IV

Latest Information Update: 11 Jan 2020

Price : $35 *
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs Dutasteride/tamsulosin (Primary)
  • Indications Benign prostatic hyperplasia
  • Focus Therapeutic Use
  • Sponsors GlaxoSmithKline
  • Most Recent Events

    • 11 Jan 2020 Results of post hoc analysis assessing the impact of baseline characteristics on Mens Sexual Health Questionnaire (MSHQ) total scores and evaluating the clinical relevance of MSHQ changes and their association with spontaneously reported sexual adverse events in patients with benign prostatic hyperplasia published in the International Journal of Clinical Practice
    • 13 Oct 2018 Results of a post-hoc analysis published in the International Journal of Clinical Practice.
    • 16 Oct 2017 Primary endpoint of total MSHQ scores at month 12 has been met, according to results published in the BJU International.
Subscriber content

You need to be a logged in subscriber to view this content.

If your organization has a subscription then there are several options available to help you access AdisInsight, even while working remotely.

  • IP authentication when working within your organization’s network.
  • with a username/password associated to your organization’s account.
  • Persisted access using your organization’s identifier stored in your user browser for 90 days.
  • Federated access using single sign-on credentials.
  • Contact us at AsktheExpert.AdisInsight@springer.com for assistance.

If your organization does not have a subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Buy a PDF version of the profile.
  • Request a free trial
Back to top